Informatie

Op 8 en 9 juni zijn de meeste UvA-gebouwen en voorzieningen dicht ivm Pinksteren. Sommige UB-locaties blijven openExterne link.

student.uva.nl
Welke opleiding volg je?
UvA Logo
Welke opleiding volg je?
Informatie

Op 8 en 9 juni zijn de meeste UvA-gebouwen en voorzieningen dicht ivm Pinksteren. Sommige UB-locaties blijven openExterne link.

Colloquiumpunten

Presentation Master's thesis - Yiming Zhao - Brain & Cognition

Colloquiumpunten

Presentation Master's thesis - Yiming Zhao - Brain & Cognition

Laatst gewijzigd op 05-06-2025 13:52
The effect of subjective dopaminergic medication states on working memory and reinforcement learning in Parkinson’s disease
Toon informatie voor jouw opleiding
Welke opleiding volg je?
of
event-summary.start-date
25-06-2025 14:00
event-summary.end-date
25-06-2025 15:00
event-summary.location

Roeterseilandcampus - Gebouw C, Straat: Nieuwe Achtergracht 129-B, Ruimte: GS.01. Vanwege beperkte zaalcapaciteit is deelname op basis van wie het eerst komt, het eerst maalt. Leraren moeten zich hieraan houden.

Parkinson’s disease (PD) patients have been found to exhibit dopamine-dependent learning impairments. However, performance on learning tasks depends on reinforcement learning (RL) and working memory (WM). It remains unclear whether learning impairments in PD are attributed to RL or WM. We hypothesize that dopaminergic medication improves RL and WM and that PD patients demonstrate dopamine-dependent RL deficits compared to healthy controls after WM deficits are controlled. A total of 191 PD patients and 50 healthy controls were recruited. PD patients rated their subjective dopaminergic medication states on self-report scales, and all participants completed the now well-established Reinforcement Learning Working Memory task. We will adopt computational modeling approaches to disentangle the contributions of RL and WM and test the effects of medication states on RL after controlling for WM. The study has implications for a better understanding of how dopaminergic medication influences cognitive performance, thus providing insights for individualized PD treatments.